(Q35842275)

10 August 2017

1 reference

title

Helicase primase: targeting the Achilles heel of herpes simplex viruses (English)

1 reference

10 August 2017

Gerald Kleymann

1

1 reference

10 August 2017

1 May 2004

1 reference

Antiviral Chemistry & Chemotherapy

10 August 2017

1 reference

10 August 2017

15

1 reference

10 August 2017

3

1 reference

10 August 2017

135-140

1 reference

Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

New anti-HSV therapeutics target the helicase-primase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Development of new antivirals for herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Helicases as antiviral drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Novel agents and strategies to treat herpes simplex virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Recent progress in herpes simplex virus immunobiology and vaccine research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Major domain swiveling revealed by the crystal structures of complexes of E. coli Rep helicase bound to single-stranded DNA and ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Synthesis and biological activities of iododeoxyuridine, an analog of thymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

Herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500303

10.1177/095632020401500303

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15266895